Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Recent
Upcoming
Share :

2022 Genitourinary Cancers Symposium

Videos
News
ASCO GU 2022: Olaparib plus abiraterone reduced risk of disease progression by 34% vs. standard-of-care in 1st-line metastatic castration-resistant prostate cancer
ASCO GU 2022: Olaparib plus abiraterone reduced risk of disease progression by 34% vs. standard-of-care in 1st...
ASCO GU: MRI-guided radiotherapy appears to lead to fewer side effects from treatment for prostate cancer
ASCO GU: MRI-guided radiotherapy appears to lead to fewer side effects from treatment for prostate cancer
ASCO GU 2022: Biomarker may help predict survival in patients with bladder cancer
ASCO GU 2022: Biomarker may help predict survival in patients with bladder cancer
ASCO GU 2022: New genetic risk score stratifies lifetime risk of dying of prostate cancer in diverse populations
ASCO GU 2022: New genetic risk score stratifies lifetime risk of dying of prostate cancer in diverse populations

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation